In this high-yield medical education podcast, we dive into angiotensin II (Giapreza) — a unique vasopressor that targets the renin-angiotensin-aldosterone system (RAAS) and is FDA-approved for vasodilatory shock. Whether you're in training or practicing in the ICU, this video provides a concise and clinically focused breakdown of how and when to use angiotensin II at the bedside.
📌 This video covers: What is angiotensin II and how does it work? Mechanism of action in the RAAS cascade. Target receptors (AT1 receptor) and hemodynamic effects. Clinical indications: septic shock, vasoplegia, catecholamine-refractory hypotension. Side effects, risks, and patient selection. Landmark evidence: ATHOS-3 trial, guideline use. Summary review + board-style practice questions.
📚 Related Resources:
Download our angiotensin II study guide and practice questions:
https://www.patreon.com/collection/1443765
Watch next: Playlist Vasopressors and Inotropes:
https://youtube.com/playlist?list=PLf5bMa9_tvRg_nAnm91hsyHhI0y_ahoS1&si=Myz25vHJgHAp4Nvc
📰👇SIGN UP FOR OUR FREE WEEKLY NEWSLETTER👍👍 https://whiteboardmedicine.kit.com/634ccbe783
👍Become a WhiteBoard Medicine member for early access and perks! https://www.youtube.com/channel/UCiMhM7xCTT8b5SJRnhpH7Ag/join
👇DON'T MISS OUT - JOIN OUR PATREON COMMUNITY TODAY 👇 https://www.patreon.com/WhiteBoardMedicine We appreciate the support!
DISCLAIMER THIS PODCAST DOES NOT PROVIDE MEDICAL ADVICE. The information, including but not limited to, audio, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read, watched, or listened to on this video, or any other videos, reports, texts tweets or other sources.
